Cód QR

Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan

This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously rece...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Toshiaki Goseki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, Kousuke Baba, Hideki Chuman, Masahiro Hashizuka, Shohei Tateishi, Akiko Kimura
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: MDPI AG 2026-02-01
Sraith:Toxins
Ábhair:
blepharospasm
botulinum toxin
dystonia
East Asia
efficacy
incobotulinumtoxinA
Rochtain ar líne:https://www.mdpi.com/2072-6651/18/2/109
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla